Acne treatment advertising: what practices can claim

Acne is one of the most searched skin problems, and acne ads tend to promise a lot: “clear skin in 30 days,” “FDA-approved acne laser,” “the acne treatment that finally works,” “no more breakouts.” Most of these are health claims about a disease, and federal law asks whether you can prove them before you publish. Some also touch FDA rules on drugs and devices, and many reach teenagers.

This guide is for dermatology practices, med spas and other clinics that treat acne. It covers clear-skin promises, over-the-counter and prescription treatments, light and laser devices, teen audiences, before-and-after photos and package prices. We do not name any drug, product, device or company. For the wider specialty, see our guide to dermatology practice marketing.

This is general information, not legal or medical advice. Sources cited were checked on November 2, 2026: 21 CFR 333 subpart D (the FDA over-the-counter acne drug monograph), 21 CFR 202.1, 21 CFR 807.97, and 16 CFR 233.1, 255.2, 255.5 and 312 in the eCFR version as of October 29, 2026; FDA product classification records for product codes OLP and OZC; FDA’s isotretinoin information page; the NIAMS (National Institutes of Health) health topic page on acne; 15 USC 45 and 52 and 21 USC 321 in the Cornell LII text of the U.S. Code; and the FTC Health Products Compliance Guidance (December 2022). We did not read any state medical board rule. Who may perform which acne procedures, and who may supervise them, depends on your state. Check with your board and counsel before you advertise.

The short version

Acne is a disease under federal rules. FDA’s acne monograph defines acne as a disease of the oil glands and hair follicles. “Clears acne” is a disease claim and needs competent and reliable scientific evidence.
Do not promise clear skin. “Guaranteed clear skin” or “acne-free for good” describes an outcome you cannot promise every patient. Describe the treatment and what is typical.
“FDA-cleared” is not “FDA-approved.” Under 21 CFR 807.97, implying official approval because a device was cleared through premarket notification is misbranding. Name the cleared use correctly.
Prescription treatments need balance. FDA’s prescription drug ad rules apply to manufacturers and distributors, but the FTC Act applies to you. Mention risks and who is a candidate, not only benefits.
Teens are a large share of acne patients. Children’s privacy rules apply to sites directed to children under 13, and state consent rules for minors vary.
Reviews and photos count as your claims. A featured “cleared my acne in two weeks” review is a claim you make (16 CFR 255.2).

Who gets acne, and why the audience matters

NIAMS, part of the National Institutes of Health, says people of all races and ages get acne, but it is most common in teens and young adults. When it continues into adulthood, it is more common in women. For marketing, that means two audiences with different needs:

Teens and their parents, who often search for help with a first prescription or with acne that drugstore products have not cleared.
Adults, often women, with acne that started or returned later in life, who may be comparing a dermatologist, a med spa and an online prescribing service.

Both groups are often frustrated and self-conscious, which is why “finally clear” and “guaranteed results” wording is tempting and why it draws regulator attention. Write for the person deciding where to go, not for the most hopeful reader.

Clear-skin promises and the FTC Act

Under the FTC Act, an ad is deceptive if its net impression misleads, and health claims need competent and reliable scientific evidence (15 USC 45 and 52; FTC Health Products Compliance Guidance). Acne claims to watch:

Outcome guarantees. “Clear skin guaranteed” or “we will clear your acne” promises a result for everyone. Treatments that work for many patients do not work for all, and acne can come back after treatment stops.
Speed claims. “Results in 7 days” needs evidence for that time frame, for the treatment you name, in patients like the ones you advertise to.
Permanence. “Cure,” “gone for good” and “never break out again” need evidence of lasting results. If your evidence covers months, say months.
Comparisons. “Better than prescriptions” or “works when nothing else has” needs head-to-head evidence.
Root-cause wording. “We treat the root cause of your acne” with a facial, diet plan or supplement implies a medical effect. Keep the claim to what the service does.

Wording that is easier to support:

“We assess your skin and acne type and recommend a treatment plan. Many patients see improvement over several months.”
“Treatment options include topical medicines, prescription medicines where appropriate, and in-office procedures.”
“Results vary. Acne often needs ongoing care to stay under control.”

Over-the-counter acne products you sell

If your practice or med spa sells over-the-counter acne products, FDA’s acne monograph at 21 CFR 333 subpart D sets the terms. It lists the active ingredients that are generally recognized as safe and effective for acne, among them benzoyl peroxide at 2.5 to 10 percent and salicylic acid at 0.5 to 2 percent, and the label wording allowed for them.

The monograph’s indications are wording such as “for the treatment of acne” or “for the management of acne,” and optional statements such as “clears up most acne blemishes,” “reduces the number of acne pimples” and “helps prevent new acne pimples.” Note how measured these are: “most,” “reduces,” “helps.”
Your ads for a monograph product should stay close to that wording. “Clears up most acne pimples” matches the monograph. “Eliminates acne permanently” does not.
A product with an active ingredient or strength outside the monograph is not covered by it. If a private-label product makes acne claims, check its ingredients and label before you advertise it. Our guide to private-label supplements and skincare covers the wider rules.
Skincare sold as a cosmetic should not claim to treat acne. Under the federal Food, Drug, and Cosmetic Act, a product intended to treat a disease is a drug (21 USC 321(g)(1)).

Prescription treatments: balance, candidates and isotretinoin

FDA’s prescription drug advertising rules at 21 CFR 202.1 are aimed at ads issued by a drug’s manufacturer, packer or distributor. A practice is usually not one of those. Your ads are still covered by the FTC Act, so a one-sided ad that lists benefits and leaves out serious risks can mislead. For more on how the two agencies split this, see our guide to prescription treatment advertising.

Say that prescription treatment depends on an exam. “Prescription acne treatment, if appropriate after your visit” is accurate. “Get your acne prescription today” promises a prescription before anyone has seen the patient.
Use generic names, not brand names, and do not imply a drug works better than its labeling supports.
Isotretinoin needs particular care. FDA says it causes severe birth defects and is approved for marketing only under a restricted-distribution program, the iPLEDGE REMS, which includes all FDA-approved isotretinoin. If you mention it, say it is for selected patients, that it has a required safety program, and that the prescriber explains the requirements. Do not present it as a quick or easy fix.
Online or telehealth prescribing ads should say who prescribes, in which states, and that a clinician decides whether a prescription is appropriate. Our guide to prescription discount card marketing covers price wording for prescriptions.

Light, laser and in-office procedures

Acne ads often feature blue light, lasers, peels and extractions. Each is a separate claim.

Check the cleared use. FDA’s classification database lists acne-specific device types, for example product code OLP (over-the-counter powered light-based laser for acne) and OZC (over-the-counter thermal treatment for acne), both class II. A device cleared for one use is not cleared for every use. Before you write “FDA-cleared for acne,” confirm the clearance for the specific device names acne.
Do not say “FDA-approved” for a cleared device. 21 CFR 807.97 says premarket notification does not denote official approval, and that any representation creating that impression is misleading and is misbranding.
Scars are a separate claim. Treating active acne and treating acne scars are different uses with different evidence. Do not let a scar-device clearance stand in for an acne claim, or the reverse.
Peels and extractions. Describe what the procedure is, who performs it, how many sessions are typical and what downtime to expect. See our guides to chemical peel advertising and laser clinic marketing for procedure-specific rules.
Skin of color. If you say a light, laser or peel treatment is suitable for all skin types, you need evidence for that, and you should tell readers that the risk of pigment changes is discussed at the consultation. Our vitiligo advertising guide covers pigment-related claims.

Teens, parents and privacy

Acne ads reach many minors. Three things to plan for:

Children under 13. The Children’s Online Privacy Protection Rule (16 CFR 312) applies to websites and online services directed to children under 13, or that knowingly collect personal information from them. A booking form or quiz aimed at preteens can bring you under it. Most practices avoid this by aiming forms at parents.
Teen consent varies by state. Whether a minor can consent to dermatology care, and what a parent can see, depends on state law. Write booking pages that say a parent or guardian may need to attend or consent. Our guide to confidential teen health services covers this in more depth.
Tone. Ads that suggest teens will be rejected or bullied unless they get treatment play on fear. Speak to the problem and the options, not to shame.
Tracking. If you use ad pixels on acne pages, remember that a visit to an acne treatment or prescription page can reveal a health condition. See our guidance on tracking pixels on healthcare websites.

Before-and-after photos and reviews

Acne is visual, so photos sell. They also make claims.

A photo set shows a result. Use real patients, with written consent, treated with the treatment the ad names, and do not retouch the skin.
Keep lighting, angle, makeup and camera the same in both photos, and state how long the treatment took.
If the result is not typical, say what patients can generally expect, or choose photos that are typical (16 CFR 255.2).
A review that says “cleared my acne in a week” is a claim you adopt when you feature it. Select reviews that describe the experience rather than unusual results.
If you gave a patient a discount or free treatment for a review or photo, disclose it (16 CFR 255.5). Our guide to patient testimonials and before-and-after photos covers consent and disclosure.

Packages, memberships and prices

“Acne clearing package: 6 sessions” is fine if you say what is included and that the number of sessions a patient needs varies.
“Was $900, now $499” needs a real former price that you charged openly for a reasonable period (16 CFR 233.1).
Monthly acne memberships should say how to cancel and what happens to unused sessions.
Do not tie a refund promise to “clear skin” unless you will honor it on the terms you state.

Getting found for acne searches

Patients search “acne dermatologist near me,” “acne treatment for teens,” “adult acne treatment” and “acne scar treatment.” A clear service page for each, written for the patient, does more than one page that lists every skin service. Each page should say who treats acne, what treatment options you offer, what a first visit involves, and how to book. Our medical lead generation and healthcare SEO services help practices build these pages and track which ones lead to booked visits.

Acne ad checklist

Every claim about clearing, preventing or improving acne has evidence for the treatment you name.
No guarantees, “cure” or “permanent” wording unless you can support it.
Over-the-counter product claims match the acne monograph wording.
Prescription mentions say an exam comes first, use generic names and note risks; isotretinoin mentions name the safety program.
Device claims name the cleared use; no “FDA-approved” for cleared devices.
Forms and ads aimed at parents, not children under 13; state consent noted for teens.
Before-and-after photos consented, unretouched and typical, or with a typical-results statement.
Former prices real and documented; packages say what is included.

Can we say our acne treatment is guaranteed?

We advise against it. A guarantee implies every patient will get the result, and acne treatments do not work for everyone. If you offer a money-back policy, state its terms precisely and do not word it as a promise of clear skin.

Is acne a disease under FDA rules?

Yes. FDA’s acne drug monograph at 21 CFR 333 subpart D defines acne as a disease involving the oil glands and hair follicles of the skin. A claim that a product or service treats acne is a disease claim.

Can we call our acne light device FDA-approved?

Not if it was cleared through premarket notification. 21 CFR 807.97 says clearance does not denote official approval and that implying approval is misbranding. Say it is FDA-cleared, and only for the use the clearance covers.

Can we advertise isotretinoin?

You can say it is a treatment option for selected patients. FDA says it causes severe birth defects and is available only under the iPLEDGE REMS safety program. Mention that a prescriber decides whether it is appropriate and explains the program requirements, and use the generic name.

Can we run acne ads aimed at teenagers?

You can reach teens and parents, but forms and quizzes aimed at children under 13 can bring you under the COPPA Rule (16 CFR 312), and consent rules for minors vary by state. Many practices aim booking at parents and say a guardian may need to consent.

Can we sell our own acne products?

Yes, within the rules. An over-the-counter acne product should use an ingredient and strength listed in the acne monograph and claims close to its label wording. Skincare sold as a cosmetic should not claim to treat acne.

Acne treatment marketing: clear-skin, prescription and laser claims